Copyright
©2007 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 14, 2007; 13(46): 6231-6235
Published online Dec 14, 2007. doi: 10.3748/wjg.v13.i46.6231
Published online Dec 14, 2007. doi: 10.3748/wjg.v13.i46.6231
Table 1 Patient characteristics
| Characteristics | No. of patients |
| Median age (range) | 56 yr (29-69) |
| Sex | |
| Male | 9 |
| Female | 5 |
| Performance (ECOG) | |
| 0-1 | 12 |
| 2 | 2 |
| CEA (ng/mL) | |
| < 5 | 3 |
| ≥ 5 | 11 |
| Primary site | |
| Colon | 8 |
| Rectum | 6 |
| Sites of metastasis | |
| Liver | 7 |
| Lung | 8 |
| Lymph nodes | 7 |
| Peritoneum | 3 |
| Others | 2 |
| Number of metastasis | |
| 1 | 3 |
| ≥ 2 | 11 |
| Adjuvant chemotherapy | |
| Yes | 9 |
| No | 5 |
- Citation: Kwon HC, Oh SY, Lee S, Kim SH, Kim HJ. Bevacizumab plus infusional 5-fluorouracil, leucovorin and irinotecan for advanced colorectal cancer that progressed after oxaliplatin and irinotecan chemotherapy: A pilot study. World J Gastroenterol 2007; 13(46): 6231-6235
- URL: https://www.wjgnet.com/1007-9327/full/v13/i46/6231.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i46.6231